Bridging scales: a hybrid model to simulate vascular tumor growth and treatment response

From MaRDI portal
Publication:6201151

DOI10.1016/J.CMA.2023.116566arXiv2306.05994OpenAlexW4381158253MaRDI QIDQ6201151FDOQ6201151

Tobias Duswald, B. Wohlmuth, J. Tinsley Oden, E. A. B. F. Lima

Publication date: 25 March 2024

Published in: Computer Methods in Applied Mechanics and Engineering (Search for Journal in Brave)

Abstract: Cancer is a disease driven by random DNA mutations and the interaction of many complex phenomena. To improve the understanding and ultimately find more effective treatments, researchers leverage computer simulations mimicking the tumor growth in silico. The challenge here is to account for the many phenomena influencing the disease progression and treatment protocols. This work introduces a computational model to simulate vascular tumor growth and the response to drug treatments in 3D. It consists of two agent-based models for the tumor cells and the vasculature. Moreover, partial differential equations govern the diffusive dynamics of the nutrients, the vascular endothelial growth factor, and two cancer drugs. The model focuses explicitly on breast cancer cells over-expressing HER2 receptors and a treatment combining standard chemotherapy (Doxorubicin) and monoclonal antibodies with anti-angiogenic properties (Trastuzumab). However, large parts of the model generalize to other scenarios. We show that the model qualitatively captures the effects of the combination therapy by comparing our simulation results with previously published pre-clinical data. Furthermore, we demonstrate the scalability of the model and the associated C++ code by simulating a vascular tumor occupying a volume of 400mm3 using a total of 92.5 million agents.


Full work available at URL: https://arxiv.org/abs/2306.05994





Cites Work







This page was built for publication: Bridging scales: a hybrid model to simulate vascular tumor growth and treatment response

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6201151)